Cymbaluk-Płoska, A.; Gargulińska, P.; Chudecka-Głaz, A.; Kwiatkowski, S.; Pius-Sadowska, E.; Machaliński, B.
The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients. Diagnostics 2020, 10, 414.
https://doi.org/10.3390/diagnostics10060414
AMA Style
Cymbaluk-Płoska A, Gargulińska P, Chudecka-Głaz A, Kwiatkowski S, Pius-Sadowska E, Machaliński B.
The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients. Diagnostics. 2020; 10(6):414.
https://doi.org/10.3390/diagnostics10060414
Chicago/Turabian Style
Cymbaluk-Płoska, Aneta, Paula Gargulińska, Anita Chudecka-Głaz, Sebastian Kwiatkowski, Ewa Pius-Sadowska, and Bogusław Machaliński.
2020. "The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients" Diagnostics 10, no. 6: 414.
https://doi.org/10.3390/diagnostics10060414
APA Style
Cymbaluk-Płoska, A., Gargulińska, P., Chudecka-Głaz, A., Kwiatkowski, S., Pius-Sadowska, E., & Machaliński, B.
(2020). The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients. Diagnostics, 10(6), 414.
https://doi.org/10.3390/diagnostics10060414